Unique correlation between mutated citrullinated vimentine IgG autoantibodies and markers of systemic inflammation in rheumatoid arthritis patients

被引：18

作者：

Zahran W.E. ^{[1
]}

Mahmoud M.I. ^{[1
]}

Shalaby K.A. ^{[1
]}

Abbas M.H. ^{[2
]}

机构：

[1] Department of Biochemistry, Faculty of Science, Ain Shams University, Cairo

[2] Rheumatology Unit, Ain Shams University Hospital, Cairo

来源：

Indian Journal of Clinical Biochemistry | 2013年 / 28卷 / 3期

关键词：

Anti-mutated citrullinated vimentine antibodies; C-reactive protein; Erythrocyte sedimentation rate; Rheumatoid arthritis; Sensitivity; Specificity;

D O I：

10.1007/s12291-012-0272-1

中图分类号：

学科分类号：

摘要：

Rheumatoid arthritis (RA) is the most common inflammatory systemic autoimmune disease, primarily affecting the peripheral joints. Anti-mutated citrullinated vimentin autoantibodies (anti-MCV) of IgG isotype were shown to be a useful diagnostic marker of RA especially in RA patients who were anti-cyclic citrullinated protein autoantibodies (anti-CCP) negative. Nevertheless, published data correlates rheumatoid factor (RF), anti-CCP or anti-MCV antibodies with either erythrocyte sedimentation rate (ESR) or serum C-reactive protein (CRP) as markers of disease activity, not investigated the possible correlations of RA autoantibodies towards ESR and CRP in comparison. Herein, we aim to evaluate the usefulness of anti-MCV as a dependable marker in established RA compared with anti-CCP and RF antibodies and to examine correlations between RF, anti-CCP and anti-MCV antibodies towards ESR and serum CRP. Serum RF-IgA, RF-IgM, anti-CCP and anti-MCV levels were measured in 30 patients with RA and 40 patients with other autoimmune diseases (non-RA) compared with 20 normal subjects. Specificity, sensitivity and AUC for RF antibodies, anti-CCP and anti-MCV were calculated towards RA diagnosis. Our results showed that ESR and CRP had significantly higher values in both RA and non-RA patients compared with our healthy controls with observed significant increment in RA patients compared with non-RA patients. An important finding from our study is that 33.3 % of RA patients were anti-CCP negative but being positive towards anti-MCV. Also, in-between 36.7 up to 40 % of RA patients were RF-IgA and RF-IgM negative while being anti-MCV positive. Anti-MCV antibodies showed the highest specificity and sensitivity (97.5 and 86.6 %, respectively) towards RA diagnosis with the highest AUC value (0.920) compared with anti-CCP and RF antibodies. Correlation analyses revealed that there was no significant correlation between ESR along with CRP towards RF-IgA, RF-IgM and anti-CCP while profound highly significant correlation exhibited between ESR and CRP towards anti-MCV data (r = 0.879 and 0.994, respectively). Thus, our data suggest that the assessment of serum anti-MCV autoantibodies along with ESR and CRP considered as a simple laboratory regime for monitoring RA patients to assess and follow-up disease activity. The addition of anti-MCV autoantibodies to serologic markers in the ACR/EULAR classification criteria for RA will add points for patients with negative anti-CCP and RF antibodies. © 2012 Association of Clinical Biochemists of India.

引用

页码：272 / 276

页数：4

共 28 条

[1]

Lutteri L., Malaise M., Chapelle J.P., Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis, Clin Chim Acta, 386, pp. 76-81, (2007)

[2]

Kuna A.T., Mutated citrullinated vimentin antibodies in rheumatoid arthritis, Clin Chim Acta, 413, pp. 66-73, (2012)

[3]

Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., Et al., Rheumatoid arthritis classification criteria: An american college of rheumatology/european league against rheumatism collaborative initiative, Ann Rheum Dis, 62, pp. 1580-1588, (2010)

[4]

Sizova L., Diagnostic value of antibodies to modified citrullinated vimentin in early rheumatoid arthritis, Hum Immunol, 73, pp. 389-392, (2012)

[5]

Wener M.H., Laboratory Tests for Autoimmune Rheumatologic Disorders. Educational Review Manual in Rheumatology, pp. 1-42, (2007)

[6]

Castro C., Gourley M., Diagnostic testing and interpretation of tests for autoimmunity, J Allergy Clin Immunol, 125, 2, (2010)

[7]

Colglazier C.L., Sutej P.G., Laboratory testing in the rheumatic diseases: A practical review, South Med J, 98, pp. 185-191, (2005)

[8]

Taylor P., Gartemann J., Hsieh J., Creeden J., A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis, Autoimmun Dis., (2011)

[9]

Schellekens G.A., De Jong B.A.W., Van Den Hoogen F.H.J., Van De Putte L.B.A., Van Venrooij W.J., Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies, J Clin Invest, 101, pp. 273-281, (1998)

[10]

Szodoray P., Szabo Z., Kapitany A., Gyetvai A., Lakos G., Szanto S., Szucs G., Szekanecz Z., Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis, Autoimmun Rev, 9, pp. 140-143, (2010)

← 1 2 3 →